Table 3.
Logistic univariate and multivariate regression analyses on the association between the case fatality rate and the clinical features.
| Univariable OR (95% CI) | P-value | Multivariable OR (95%CI) | P-value | |
|---|---|---|---|---|
| Age ≥ 60years | 2.10 (0.87–5.09) | 0.101 | 0.73 (0.21–2.58) | 0.630 |
| Sex | 0.79 (0.35–1.80) | 0.580 | 0.82 (0.29–2.36) | 0.711 |
| Comorbidities | ||||
| Hypertension | 2.44 (1.06–5.59) | 0.035 | 3.29 (1.08–10.00) | 0.036 |
| Diabetes | 1.51 (0.50–4.54) | 0.466 | ||
| Treatments | ||||
| Antiviral | 1.21 (0.33–4.47) | 0.780 | ||
| Interferon | 8.51 (1.83–39.72) | 0.006 | 2.67 (0.37–19.15) | 0.328 |
| Antibiotics | 0.98 (0.28–3.47) | 0.979 | ||
| Corticosteroids | 7.67 (2.72–21.60) | < 0.001 | 4.05 (1.37–11.98) | 0.012 |
| Intravenous immunoglobulin | 6.64 (1.80–24.54) | 0.005 | 3.54 (0.54–23.13) | 0.187 |
| Albumin | 1.29 (0.21–8.06) | 0.788 | ||
| Thymosin α1 | 0.09 (0.01–0.74) | 0.025 | 0.025 (0.00–0.36) | 0.007 |
OR, odds ratio; CI, confidence interval; ARDS, acute respiratory distress syndrome; SOFA, sequential organ failure assessment. Multivariable logistic regression were adjusted for age, sex, hypertension, interferon, corticosteroids, intravenous immunoglobulin, and thymosin α1. The bold P-values indicate P < 0.05.